Evolution Equity Partners, a specialist technology investor that focuses on cybersecurity and enterprise software companies, has received a $50.8 million commitment from British Patient Capital for its third fund. This investment follows a $35 million commitment to Evolution’s second fund in 2020.
Richard Seewald, Founder and Managing Partner at Evolution Equity Partners, expressed excitement about partnering with British Patient Capital and NSSIF to support UK-based cybersecurity companies. The goal is to provide these companies with capital, knowledge, tools, and strategies to drive performance and success in the global market. Seewald stressed the critical importance of cybersecurity to the safety of UK-based enterprises, governments, and consumers.
British Patient Capital’s Investment Director of Funds, Robert Greenwood, emphasized how cybersecurity has become a crucial application across all sectors as businesses strive to protect themselves, their customers, and their products. He highlighted the evolution of cybersecurity over the last two decades and how it has become an essential component of modern business operations. This investment showcases the UK’s leadership in cybersecurity innovation and its expertise in this valuable technology sector.